In conclusions, we demonstrated for the first time that HIF-2α dictates the resistance of human pancreatic cancer cells to TRAIL under normoxic and hypoxic conditions and transcriptionally regulates survivin expression. The gene discussed is EPAS1; the disease is pancreatic neoplasm.